Gray Matter Structural and Functional Alterations in Idiopathic Blepharospasm: A Multimodal Meta-Analysis of VBM and Functional Neuroimaging Studies

Gray Matter Structural and Functional Alterations in Idiopathic Blepharospasm: A Multimodal Meta-Analysis of VBM and Functional Neuroimaging Studies

BackgroundNeuroimaging studies have shown gray matter structural and functional alterations in patients with idiopathic blepharospasm (iBSP) but with variations. Here we aimed to investigate the specific and common neurostructural/functional abnormalities in patients with iBSP.MethodsA systematic li...

Full description

Bibliographic Details
Main Authors:	Meng Zhang, Xiang Huang, Boyi Li, Huifang Shang, Jing Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Neurology
Subjects:	dystonia blepharospasm neuroimaging voxel-based morphometry meta-analysis multimodal
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.889714/full

Similar Items

A Case with Improvement of Blepharospasm by Zolpidem
by: Munkyung Sunwoo, et al.
Published: (2011-05-01)

Sexual dysfunction in cervical dystonia and blepharospasm
by: Marek M, et al.
Published: (2018-10-01)

A multimodal meta-analysis of gray matter alterations in trigeminal neuralgia
by: Xiang Huang, et al.
Published: (2023-08-01)

The pathogenesis of blepharospasm
by: Lixia Zhu, et al.
Published: (2024-01-01)

Sensory Trick Frames: A New Device for Blepharospasm Patients
by: Daniele Lorenzano, et al.
Published: (2019-01-01)

MRI morphometry in primary focal dystonia
by: S. L. Timerbaeva, et al.
Published: (2017-02-01)

Advances in the treatment of Meige's syndrome with blepharospasm
by: Jia-Wei Wu, et al.
Published: (2023-03-01)

Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm
by: Hannah Mary Timlin, et al.
Published: (2021-01-01)

Blepharospasm Patients after Botulinum Toxin – Sleep Approach
by: Silvia Lestingi, et al.
Published: (2023-03-01)

Role of modern neuroimaging in the studies of focal dystonia
by: S. L. Timerbaeva
Published: (2017-02-01)

Asymmetric Blepharospasm Treated with Botulinum Toxin-A: Case Report
by: Gözde BARAN, et al.
Published: (2019-01-01)

Association of frontal gray matter volume and cerebral perfusion in heroin addiction: A multimodal neuroimaging study
by: Niklaus eDenier, et al.
Published: (2013-10-01)

The Effect of Botulinum Toxin Type A in Patients with Essential Blepharospasm
by: Klara Gaćina, et al.
Published: (2022-01-01)

Blepharospasm as a tardive manifestation of COVID-19 disease: A case report
by: Roberta Farci, et al.
Published: (2023-01-01)

Anatomical correlates of blepharospasm
by: Horovitz Silvina G, et al.
Published: (2012-06-01)

REEP4 variant analysis in blepharospasm and other neurological disorders
by: Samira Saeirad, et al.
Published: (2024-02-01)

Psychogenic blepharospasm associated with Meige’s syndrome: a case report
by: Cagdas Oyku Memis, et al.
Published: (2018-04-01)

A Multimodal Meta-Analysis of Structural and Functional Changes in the Brain of Tinnitus
by: Shirui Cheng, et al.
Published: (2020-02-01)

Blepharospasm: Update on epidemiology, clinical aspects and pathophysiology.
by: Josep eValls-Sole, et al.
Published: (2016-03-01)

The effect on blink frequency of a selective blue-filtering photochromic lens in patients with benign essential blepharospasm
by: Tobias Monschein, et al.
Published: (2023-12-01)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
by: Leplow B, et al.
Published: (2017-09-01)

Cortico-Subcortical White Matter Bundle Changes in Cervical Dystonia and Blepharospasm
by: Costanza Giannì, et al.
Published: (2023-03-01)

Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
by: V Maneksha, et al.
Published: (2021-01-01)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
by: Travis J.W. Hassell, et al.
Published: (2020-04-01)

Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness
by: Ulysses S. Torres, et al.
Published: (2016-01-01)

Specificity of using botulinic toxin type A for blepharospasm treatment
by: A. R. Artemenko, et al.
Published: (2020-01-01)

Structural neuroimaging in patients with anorexia nervosa
by: R. V. Grebenshchikova, et al.
Published: (2022-12-01)

Botulinum toxin A in the treatment of blepharospasm: a 10-year experience Toxina botulínica tipo A no tratamento do blefaroespasmo: experiência de 10 anos de utilização
by: Laura Silveira-Moriyama, et al.
Published: (2005-06-01)

Genetic Screening of a Hungarian Cohort with Focal Dystonia Identified Several Novel Putative Pathogenic Gene Variants
by: András Salamon, et al.
Published: (2023-06-01)

Multimodal MEMPRAGE, FLAIR, and R2* Segmentation to Resolve Dura and Vessels from Cortical Gray Matter
by: Roberto Viviani, et al.
Published: (2017-05-01)

Altered gray matter volume and functional connectivity in medial orbitofrontal cortex of bulimia nervosa patients: A combined VBM and FC study
by: Wei-hua Li, et al.
Published: (2022-08-01)

Impaired Topographic Organization in Patients With Idiopathic Blepharospasm
by: Yanbing Hou, et al.
Published: (2022-01-01)

Comparing VBM and ROI analyses for detection of gray matter abnormalities in patients with bipolar disorder using MRI
by: Somayyeh Seyedi, et al.
Published: (2020-12-01)

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
by: Ruth Kent, et al.
Published: (2021-07-01)

Meta-analysis of structural and functional alterations of brain in patients with attention-deficit/hyperactivity disorder
by: Miaomiao Yu, et al.
Published: (2023-01-01)

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)

A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial
by: Sadie Lawes-Wickwar, et al.
Published: (2022-03-01)

A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling
by: Shinichi Matsumoto, et al.
Published: (2022-07-01)

Genetic Update and Treatment for Dystonia
by: Jan Koptielow, et al.
Published: (2024-03-01)

Coordinate based meta-analysis of networks in neuroimaging studies
by: C.R. Tench, et al.
Published: (2020-01-01)